Expert Discusses The Future of GLP-1 Medication, Expanded Indications

James Shehan shares insights on the promising trends shaping the weight loss medication and how changing views of obesity could pave the way for uptake GLP-1s.

Related Keywords

United States ,Lowenstein Sandler ,Ozempic Wegovy ,James Shehan ,Nova Lourdes ,Novo Nordisk ,Inflation Reduction Act ,